Isolation and Characterization of a Novel Strain of Mesenchymal Stem Cells from Mouse Umbilical Cord: Potential Application in Cell-Based Therapy

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Li, Wen Wen ^a   Wei, Yau Huei ^a,b   Li, Hung ^c   Lai, Dar Ming ^d   Lin, Teng Nan ^a,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

^c INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; GREEN FLUORESCENT PROTEIN; RNA;

ACUTE LIVER FAILURE; ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL SHAPE; CELL STRAIN; CELL STRUCTURE; CELLULAR PARAMETERS; CONTROLLED STUDY; DOUBLING TIME; ENGRAFTMENT; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL; NONHUMAN; OSTEOBLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL CULTURE; SURVIVAL RATE; TRANSGENIC MOUSE; UMBILICAL CORD; WILD TYPE;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; OSTEOBLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROKE; UMBILICAL CORD;

EID: 84883164526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074478     Document Type: Article

References (64)

1. Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, et al. (2004) In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40: 1275-1284. doi:10.1002/hep.20469. PubMed: 15562440.
2. Chao KC, Chao KF, Fu YS, Liu SH, (2008) Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLOS ONE 3: e1451. doi:10.1371/journal.pone.0001451. PubMed: 18197261.
3. Zanini C, Bruno S, Mandili G, Baci D, Cerutti F, et al. (2011) Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotype. PLOS ONE 6: e28175. doi:10.1371/journal.pone.0028175. PubMed: 22194812.
4. Greco SJ, Zhou C, Ye JH, Rameshwar P, (2007) An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev 16: 811-826. doi:10.1089/scd.2007.0011. PubMed: 17999602.
5. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, et al. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843. doi:10.1182/blood.V99.10.3838. PubMed: 11986244.
6. Nauta AJ, Fibbe WE, (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506. doi:10.1182/blood-2007-02-069716. PubMed: 17664353.
7. Castillo MD, Trzaska KA, Greco SJ, Ponzio NM, Rameshwar P, (2008) Immunostimulatory effects of mesenchymal stem cell-derived neurons: implications for stem cell therapy in allogeneic transplantations. Clin. Transl Sci 1: 27-34. doi:10.1111/j.1752-8062.2008.00018.x.
8. Zhao S, Wehner R, Bornhäuser M, Wassmuth R, Bachmann M, et al. (2010) Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev 19: 607-614. doi:10.1089/scd.2009.0345. PubMed: 19824807.
9. Ben-Ami E, Berrih-Aknin S, Miller A, (2011) Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. Autoimmun Rev 10: 410-415. doi:10.1016/j.autrev.2011.01.005. PubMed: 21256250.
10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. doi:10.1126/science.284.5411.143. PubMed: 10102814.
11. Luria EA, Panasyuk AF, Friedenstein AY, (1971) Fibroblast colony formation from monolayer cultures of blood cells. Transfusion 11: 345-349. doi:10.1111/j.1537-2995.1971.tb04426.x. PubMed: 5136066.
12. Tuli R, Tuli S, Nandi S, Wang ML, Alexander PG, et al. (2003) Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells 21: 681-693. doi:10.1634/stemcells.21-6-681. PubMed: 14595128.
13. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP, (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44: 1928-1942. doi:10.1002/1529-0131(200108)44:8. PubMed: 11508446.
14. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228. doi:10.1089/107632701300062859. PubMed: 11304456.
15. Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, et al. (2004) Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 22: 649-658. doi:10.1634/stemcells.22-5-649. PubMed: 15342929.
16. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, et al. (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22: 1338-1345. doi:10.1634/stemcells.2004-0058. PubMed: 15579651.
17. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, et al. (1998) Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A 95: 8801-8805. doi:10.1073/pnas.95.15.8801. PubMed: 9671759.
18. Young HE, Mancini ML, Wright RP, Smith JC, Black AC Jr., et al. (1995) Mesenchymal stem cells reside within the connective tissues of many organs. Dev Dyn 202: 137-144. doi:10.1002/aja.1002020205. PubMed: 7734732.
19. Pierdomenico L, Bonsi L, Calvitti M, Rondelli D, Arpinati M, et al. (2005) Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation 80: 836-842. doi:10.1097/01.tp.0000173794.72151.88. PubMed: 16210973.
20. Hu Y, Liao L, Wang Q, Ma L, Ma G, et al. (2003) Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med 141: 342-349. doi:10.1016/S0022-2143(03)00022-2. PubMed: 12761478.
21. Bieback K, Kern S, Klüter H, Eichler H, (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22: 625-634. doi:10.1634/stemcells.22-4-625. PubMed: 15277708.
22. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, et al. (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103: 1669-1675. doi:10.1182/blood-2003-05-1670. PubMed: 14576065.
23. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, et al. (2004) Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22: 1330-1337. doi:10.1634/stemcells.2004-0013. PubMed: 15579650.
24. Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, et al. (2003) Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 21: 50-60. doi:10.1634/stemcells.21-1-50. PubMed: 12529551.
25. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, et al. (2007) Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25: 319-331. doi:10.1634/stemcells.2006-0286. PubMed: 17053211.
26. Ding DC, Shyu WC, Chiang MF, Lin SZ, Chang YC, et al. (2007) Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis 27: 339-353. doi:10.1016/j.nbd.2007.06.010. PubMed: 17651977.
27. Troyer DL, Weiss ML, (2008) Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26: 591-599. doi:10.1634/stemcells.2007-0439. PubMed: 18065397.
28. Guillot PV, Gotherstrom C, Chan J, Kurata H, Fisk NM, (2007) Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25: 646-654. PubMed: 17124009.
29. Baksh D, Yao R, Tuan RS, (2007) Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25: 1384-1392. doi:10.1634/stemcells.2006-0709. PubMed: 17332507.
30. Chao YH, Wu HP, Chan CK, Tsai C, Peng CT, et al. (2012) Umbilical cord-derived mesenchymal stem cells for hematopoietic stem cell transplantation. J Biomed Biotechnol, 2012(2012): 759503. PubMed: 23093863.
31. Cai J, Li W, Su H, Qin D, Yang J, et al. (2010) Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 285: 11227-11234. doi:10.1074/jbc.M109.086389. PubMed: 20139068.
32. Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, et al. (2006) Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24: 115-124. doi:10.1634/stemcells.2005-0053. PubMed: 16099997.
33. Koh SH, Kim KS, Choi MR, Jung KH, Park KS, et al. (2008) Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 1229: 233-248. doi:10.1016/j.brainres.2008.06.087. PubMed: 18634757.
34. Liao W, Xie J, Zhong J, Liu Y, Du L, et al. (2009) Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 87: 350-359. doi:10.1097/TP.0b013e318195742e. PubMed: 19202439.
35. Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H, et al. (2008) Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PLOS ONE 3: e3336. doi:10.1371/journal.pone.0003336. PubMed: 18852872.
36. Tsai PC, Fu TW, Chen YM, Ko TL, Chen TH, et al. (2009) The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl 15: 484-495. doi:10.1002/lt.21715. PubMed: 19399744.
37. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, et al. (2009) Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 175: 303-313. doi:10.2353/ajpath.2009.080629. PubMed: 19497992.
38. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, et al. (2005) Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33: 1402-1416. doi:10.1016/j.exphem.2005.07.003. PubMed: 16263424.
39. Zhou Z, Chen Y, Zhang H, Min S, Yu B, et al. (2013) Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury. Cytotherapy 15: 434-448. doi:10.1016/j.jcyt.2012.11.015. PubMed: 23376106.
40. Sigrist S, Ebel N, Langlois A, Bosco D, Toso C, et al. (2005) Role of chemokine signaling pathways in pancreatic islet rejection during allo- and xenotransplantation. Transplant Proc 37: 3516-3518. doi:10.1016/j.transproceed.2005.09.048. PubMed: 16298647.
41. Revell CM, Athanasiou KA, (2009) Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects. Tissue Eng B Rev 15: 1-15. doi:10.1089/ten.teb.2008.0189. PubMed: 19063664.
42. Carlin R, Davis D, Weiss M, Schultz B, Troyer D, (2006) Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol 4: 8. doi:10.1186/1477-7827-4-8. PubMed: 16460563.
43. Cardoso TC, Ferrari HF, Garcia AF, Novais JB, Silva-Frade C, et al. (2012) Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system. BMC Biotechnol 12: 18. doi:10.1186/1472-6750-12-18. PubMed: 22559872.
44. Iacono E, Brunori L, Pirrone A, Pagliaro PP, Ricci F, et al. (2012) Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse. Reproduction 143: 455-468. doi:10.1530/REP-10-0408. PubMed: 22274885.
45. Lee KS, Nah JJ, Lee BC, Lee HT, Lee HS, et al. (2013) Maintenance and characterization of multipotent mesenchymal stem cells isolated from canine umbilical cord matrix by collagenase digestion. Res Vet Sci 94: 144-151. doi:10.1016/j.rvsc.2012.07.033. PubMed: 22975229.
46. Bai C, Li X, Hou L, Zhang M, Guan W, et al. (2013) Biological characterization of chicken mesenchymal stem/progenitor cells from umbilical cord Wharton's jelly. Mol Cell Biochem 376: 95-102. doi:10.1007/s11010-012-1553-y. PubMed: 23275127.
47. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49. doi:10.1038/nature00870. PubMed: 12077603.
48. Chu MS, Chang CF, Yang CC, Bau YC, Ho LL, et al. (2006) Signalling pathway in the induction of neurite outgrowth in human mesenchymal stem cells. Cell Signal 18: 519-530. doi:10.1016/j.cellsig.2005.05.018. PubMed: 16098715.
49. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL, (1999) Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 283: 534-537. doi:10.1126/science.283.5401.534. PubMed: 9915700.
50. Jackson KA, Mi T, Goodell MA, (1999) Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A 96: 14482-14486. doi:10.1073/pnas.96.25.14482. PubMed: 10588731.
51. Miranda AS, Rodrigues DH, Vieira LB, Lima CX, Rachid MA, et al. (2010) A thioacetamide-induced hepatic encephalopathy model in C57BL/6 mice: a behavioral and neurochemical study. Arq Neuro Psiquiatr 68: 597-602. doi:10.1590/S0004-282X2010000400022. PubMed: 20730316.
52. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD, (1986) A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 17: 738-743. doi:10.1161/01.STR.17.4.738. PubMed: 2943059.
53. Lin TN, He YY, Wu G, Khan M, Hsu CY, (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24: 117-121. doi:10.1161/01.STR.24.1.117. PubMed: 8418534.
54. Harting MT, Jimenez F, Cox CS Jr., (2009) Isolation of mesenchymal stem cells (MSCs) from green fluorescent protein positive (GFP+) transgenic rodents: the grass is not always green(er). Stem Cells Dev 18: 127-135. doi:10.1089/scd.2008.0046. PubMed: 18518666.
55. Zhang S, Chen L, Liu T, Zhang B, Xiang D, et al. (2012) Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation. Tissue Eng A 18: 1352-1364. doi:10.1089/ten.tea.2011.0516. PubMed: 22519429.
56. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, et al. (2009) Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol 24: 70-77. doi:10.1111/j.1440-1746.2008.05496.x. PubMed: 18624899.
57. Hwang S, Hong HN, Kim HS, Park SR, Won YJ, et al. (2012) Hepatogenic differentiation of mesenchymal stem cells in a rat model of thioacetamide-induced liver cirrhosis. Cell Biol Int 36: 279-288. doi:10.1042/CBI20110325. PubMed: 21966929.
58. Yu J, Cao H, Yang J, Pan Q, Ma J, et al. (2012) In vivo hepatic differentiation of mesenchymal stem cells from human umbilical cord blood after transplantation into mice with liver injury. Biochem Biophys Res Commun 422: 539-545. doi:10.1016/j.bbrc.2012.04.156. PubMed: 22580002.
59. Tögel F, Weiss K, Yang Y, Hu Z, Zhang P, et al. (2007) Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292: F1626-F1635. doi:10.1152/ajprenal.00339.2006. PubMed: 17213465.
60. Kim SJ, Park KC, Lee JU, Kim KJ, Kim DG, (2011) Therapeutic potential of adipose tissue-derived stem cells for liver failure according to the transplantation routes. J Korean Surg Soc 81: 176-186. doi:10.4174/jkss.2011.81.3.176. PubMed: 22066119.
61. Meirelles Lda S, Fontes AM, Covas DT, Caplan AI, (2009) Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20: 419-427. doi:10.1016/j.cytogfr.2009.10.002. PubMed: 19926330.
62. Burdon TJ, Paul A, Noiseux N, Prakash S, Shum-Tim D, (2011) Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. Bone Marrow Res, 2011(2011): 207326. PubMed: 22046556.
63. Liu WH, Liu JJ, Wu J, Zhang LL, Liu F, et al. (2013) Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway. PLOS ONE 8: e55487. doi:10.1371/journal.pone.0055487. PubMed: 23383203.
64. Ryan JM, Barry FP, Murphy JM, Mahon BP, (2005) Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2: 8. doi:10.1186/1476-9255-2-8. PubMed: 16045800.